Search Results - "Bañas, Stefanie"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion by Holder, Patrick G., Jones, Lesley C., Drake, Penelope M., Barfield, Robyn M., Bañas, Stefanie, de Hart, Gregory W., Baker, Jeanne, Rabuka, David

    Published in The Journal of biological chemistry (19-06-2015)
    “…To further our aim of synthesizing aldehyde-tagged proteins for research and biotechnology applications, we developed methods for recombinant production of…”
    Get full text
    Journal Article
  3. 3

    Site-Specific Tandem Knoevenagel Condensation–Michael Addition To Generate Antibody–Drug Conjugates by Kudirka, Romas A, Barfield, Robyn M, McFarland, Jesse M, Drake, Penelope M, Carlson, Adam, Bañas, Stefanie, Zmolek, Wes, Garofalo, Albert W, Rabuka, David

    Published in ACS medicinal chemistry letters (10-11-2016)
    “…Expanded ligation techniques are sorely needed to generate unique linkages for the growing field of functionally enhanced proteins. To address this need, we…”
    Get full text
    Journal Article
  4. 4

    A simple LC/MRM–MS-based method to quantify free linker-payload in antibody-drug conjugate preparations by Zmolek, Wesley, Bañas, Stefanie, Barfield, Robyn M., Rabuka, David, Drake, Penelope M.

    “…•A simple MRM-based method to quantify free linker-payload in an ADC is described.•The approach has an LLOQ of 10nM and requires no special laboratory…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Antibody-drug conjugate library prepared by scanning insertion of the aldehyde tag into IgG1 constant regions by Huang, Betty C B, Kim, Yun Cheol, Bañas, Stefanie, Barfield, Robyn M, Drake, Penelope M, Rupniewski, Igor, Haskins, William E, Rabuka, David

    Published in mAbs (17-11-2018)
    “…The advantages of site-specific over stochastic bioconjugation technologies include homogeneity of product, minimal perturbation of protein structure/function,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Exploring the effects of linker composition on site-specifically modified antibody–drug conjugates by Albers, Aaron E., Garofalo, Albert W., Drake, Penelope M., Kudirka, Romas, de Hart, Gregory W., Barfield, Robyn M., Baker, Jeanne, Banas, Stefanie, Rabuka, David

    Published in European journal of medicinal chemistry (17-12-2014)
    “…In the context of antibody–drug conjugates (ADCs), noncleavable linkers provide a means to deliver cytotoxic small molecules to cell targets while reducing…”
    Get full text
    Journal Article
  12. 12

    Antibody-drug conjugate library prepared by scanning insertion of the aldehyde tag into IgG1 constant regions by Huang, Betty C. B., Kim, Yun Cheol, Bañas, Stefanie, Barfield, Robyn M., Drake, Penelope M., Rupniewski, Igor, Haskins, William E., Rabuka, David

    Published in mAbs (17-11-2018)
    “…The advantages of site-specific over stochastic bioconjugation technologies include homogeneity of product, minimal perturbation of protein structure/function,…”
    Get full text
    Report
  13. 13

    Generating Site-Specifically Modified Proteins via a Versatile and Stable Nucleophilic Carbon Ligation by Kudirka, Romas, Barfield, Robyn M., McFarland, Jesse, Albers, Aaron E., de Hart, Gregory W., Drake, Penelope M., Holder, Patrick G., Banas, Stefanie, Jones, Lesley C., Garofalo, Albert W., Rabuka, David

    Published in Chemistry & biology (19-02-2015)
    “…There is a need for facile chemistries that allow for chemo- and regioselectivity in bioconjugation reactions. To address this need, we are pioneering…”
    Get full text
    Journal Article